7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway

Cancer Chemotherapy and Pharmacology
Tzu-Sheng HsuJui-I Chao

Abstract

The derivatives of 5,8-quinolinedione have been shown to exert anticancer activities. A new synthetic compound 7-chloro-6-piperidin-1-yl-quinoline-5,8-dione (designed as PT-262) derived from 6,7-dichloroquinoline-5,8-dione on its anticancer activity was investigated in this study. PT-262 was synthesized as the following: triethylamine (0.56 ml, 5.1 mmol) was added dropwise to a solution of 6,7-dichloroquinoline-5,8-dione (1.00 g, 4.4 mmol) and piperidine (0.50 ml, 5.1 mmol) in 150 ml of benzene with stirring at room temperature for 5 min, and the solvent was removed using rotary evaporator to give a dark brown solid. PT-262 was purified by flash chromatography using 50% ethyl acetate/hexanes to elute that displayed as brown solids. To examine the induction of apoptosis following PT-262 treatment, the lung cancer cells were subjected to apoptotic cell observation, caspase activation, and mitochondrial functional assays. The protein levels of phosphorylated ERK and CDC2 after treatment with PT-262 were analyzed by Western blot. Treatment with 1-20 microM PT-262 for 24 h induced cytotoxicity via a concentration-dependent manner in human lung cancer cells. PT-262 induced the loss of mitochondrial membrane potential and elevated the...Continue Reading

References

Oct 1, 1985·Chemico-biological Interactions·D RossP Moldeus
Nov 15, 1986·Archives of Biochemistry and Biophysics·L RossiP J O'Brien
Nov 1, 1995·Molecular and Cellular Biology·Z HanE A Hendrickson
Nov 18, 1994·Cell·R W KingM W Kirschner
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M A JordanL Wilson
Dec 1, 1995·Current Opinion in Cell Biology·A J Waskiewicz, J A Cooper
Feb 1, 1996·Current Opinion in Genetics & Development·S Bates, K H Vousden
Mar 4, 2000·Toxicological Sciences : an Official Journal of the Society of Toxicology·J S Isenberg, J E Klaunig
Feb 8, 2002·Cell·Ricky W JohnstoneScott W Lowe
Sep 10, 2002·Bioorganic & Medicinal Chemistry Letters·Chinpiao ChenHuan-Yi Tseng
Dec 5, 2002·The Journal of Clinical Investigation·Dimitri LodyginHeiko Hermeking
Jan 23, 2003·Carcinogenesis·Susan W P WijnhovenHarry Vrieling
May 1, 2004·Trends in Pharmacological Sciences·Lorne J HofsethCurtis C Harris

❮ Previous
Next ❯

Citations

Jun 19, 2015·Expert Opinion on Drug Discovery·Yuan Lin, Yi Zheng
Oct 3, 2009·The Journal of Antibiotics·Yiqing LiXueshi Huang
May 11, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Julio BenitesPedro Buc Calderon
Nov 20, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Monika Kadela-TomanekStanisław Boryczka
Jul 30, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Graziella Ribeiro de SousaMaría Sol Brassesco

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis